Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was released (replacing v3.3.3). There are no substantive changes to the study details or layout.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe Study Locations section was expanded to include numerous investigational sites in the US and internationally (Argentina, China, France, Japan, Mexico, Russia, South Korea, and more). This broadens recruitment geography.SummaryDifference2%

- Check53 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed-focused note and revision text (v3.2.0) were removed.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a new publication citation to the Publications section (Kim BS et al., Am J Clin Dermatol, 2025) and removed a generic NIH funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedAn updated last update timestamp and minor formatting changes are visible; core study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

- Check104 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.